Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Limit use of nasal decongestant sprays to five days, UK regulator says

New advice to limit the use of nasal decongestant sprays containing xylometazoline and oxymetazoline to a maximum of […]

May 4, 2026 Respiratory medicine

Cancer: Under a third of patients get diagnosis within 28 days at some hospitals

Fewer than a third of cancer patients in some hospitals are getting a diagnosis within the NHS’s 28 […]

May 4, 2026 Oncology, UK

OLOPATADINE HYDROCHLORIDE solution [Best Choice]

Updated Date: Fri, 24 Apr 2026 00:00:00 EDT

May 2, 2026 Uncategorized

PROPRANOLOL HYDROCHLORIDE tablet [REMEDYREPACK INC.]

Updated Date: Fri, 24 Apr 2026 00:00:00 EDT

May 2, 2026 Uncategorized

FLUTICASONE PROPIONATE spray, metered [Preferred Pharmaceuticals Inc.]

Updated Date: Fri, 24 Apr 2026 00:00:00 EDT

May 2, 2026 Uncategorized

ATENOLOL tablet [Preferred Pharmaceuticals Inc.]

Updated Date: Fri, 24 Apr 2026 00:00:00 EDT

May 2, 2026 Uncategorized

PAIN RELIEVER (acetaminophen) tablet [Walgreen Company]

Updated Date: Fri, 24 Apr 2026 00:00:00 EDT

May 2, 2026 Uncategorized

Myomaker Bio unveils lab‑grown human muscle platform to transform drug testing

Myomaker Bio unveils lab‑grown human muscle platform to transform drug testing
p p Read More

UK spin‑out speeds up development and reduces animal testing

April 30, 2026 News

Survodutide delivers 16.6% weight loss in major phase 3 obesity trial

Survodutide delivers 16.6% weight loss in major phase 3 obesity trial
p p Read More

Boehringer Ingelheim reports significant reductions in weight

April 30, 2026 News

Kahimmune Therapeutics signs collaboration agreement with Gustave Roussy

Kahimmune Therapeutics signs collaboration agreement with Gustave Roussy
p p Read More

Partnership to support selection of first neoantigen therapy candidate

April 29, 2026 News

Posts navigation

Posts pagination

« Previous 1 2 3 … 1,983 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy